Music And Psychedelics – An Interview With Mendel Kaelen

The following is a small snippet from the excellent article here at drug reporter   DoS: How did you discover psychedelics then? MK: Because of my fascination with the altered states of consciousness described in Monroe’s book, I read articles about ketamine’s ability to induce similar states, and about ayahuasca and other psychedelics used in traditional …

Read moreMusic And Psychedelics – An Interview With Mendel Kaelen

Risky research could herald mindful revolution

  Pioneering research into psychedelic drugs could herald a revolution in our understanding of human consciousness and how we treat mental illness.       With its roots in the great age of Victorian invention, Imperial College London looks back on a rich heritage of breakthroughs in science, engineering and medicine – from the discovery …

Read moreRisky research could herald mindful revolution

Psychedelic expert: Shrooms will be approved for depression in 10 years

Ask a healthy person who’s tripped on psychedelics what it felt like, and they’ll probably tell you they saw sounds or heard colors: The crash-bang of a dropped box took on an aggressive,dark shape. A bright green light seemed to emit a piercing, high-pitched screech. In actuality, this “cross-wiring” — synaesthesia, as it’s known scientifically — may …

Read morePsychedelic expert: Shrooms will be approved for depression in 10 years

David Nutt – The Psychedelic Crusader

  David Nutt The Psychedelic Crusader In a society where almost all drugs have negative associations, it’s hard to have an open and rational discussion about their potential miraculous effects. /.post__head 52 Insights David Nutt The Psychedelic Crusader • 12th/Jan/2017 For almost 50 years LSD was banned worldwide and under no circumstances was any scientific …

Read moreDavid Nutt – The Psychedelic Crusader

Magic Mushrooms Could Be the Future of Antidepressants

We spoke to Dr. Mark Bolstridge, a clinical psychiatrist searching for alternative and unusual treatments for depression.

Bolstridge, alongside David Nutt, president of the British Neuroscience Association and former government drugs advisor, initially applied to run a psilocybin trial in 2013. Nutt had previously conducted small experiments before more stringent regulations around psychoactive substances were put into place. He felt that psilocybin had the potential to alleviate symptoms of depression and wanted to carry out further experiments.

Bolstridge is already in the process of searching for alternative and unusual treatments. In particular, he’s been looking into the hallucinogenic compound found within magic mushrooms: psilocybin.

“There are a distinct proportion of patients who don’t get better despite taking lots of different antidepressants,” says Dr. Mark Bolstridge, an honorary research associate at UCL and a clinical psychiatrist. “That’s frustrating as a clinician, that even though we do have a lot of drugs at our disposal, for some people, none of them work.”

found that some drug companies were selectively publishing studies on antidepressants that showed the drugs had a benefit and shelving others that showed there was no overall effect.

, doctors treat the causes in a crude way, with drugs “aimed at the wrong target,” often focusing on reducing stress rather than depression itself. Others have suggested that

The science of antidepressants, is not, as it goes, an exact science. Two patients can react differently to the same drug. For some people, many of the existing drugs won’t have any effect at all.

 

 

Psilocybin for treatment-resistant depression

Twelve people with moderate to severe treatment-resistant depression who had not responded to at least two courses of antidepressants were recruited (six men and six women, aged 30 to 64). Most of the participants actively volunteered to take part following presentations by the researchers and media coverage. Hallucinogenics such as psilocybin can cause unpleasant reactions, …

Read morePsilocybin for treatment-resistant depression